Transcription of The Investigational New Drug (IND) and New Drug ...
{{id}} {{{paragraph}}}
Example: bankruptcy
The Investigational New Drug (IND) and New Drug ...
The Investigational New drug (IND) and New drug Application (NDA) ProcessSusan Honig, MDDivision of Oncology drug ProductsUS Food & drug AdministrationPublic DomainRelevant Laws Federal Food, drug , and Cosmetic Act Public Health Service Act--Part F Licensing of Biological Products and Clinical LaboratoriesRelevant Regulations IND regulations (both drugs and biologics) 21 CFR 312 NDA (drugs) regulations--21 CFR 314 Product licensing (biologics)--21 CFR 601 Protection of human subjects and informed consent regulations--21 CFR 50 IRB regulations--21 CFR 56 Basis for NDA Approval Demonstration of efficacy with acceptable safety in adequate and well-controlled studies Ability to generate product labeling that Defines an appropriate patient population for treatment with the drug Provides adequate information to enable safe and effective use of the drugBasis of BLA Approval Lic
The Investigational New Drug (IND) and New Drug Application (NDA) Process Susan Honig, MD Division of Oncology Drug Products. US Food & Drug Administration
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: